Philip Morris International Inc
146.77-3.04 (-2.03%)
Oct 29, 4:00:02 PM EDT · NYSE · PM · USD
Key Stats
Market Cap
228.47BP/E (TTM)
20.91Basic EPS (TTM)
7.02Dividend Yield
0.04%Recent Filings
8-K
8-K
PMI boosts smoke-free growth
Philip Morris International reported Q3 2025 results with adjusted diluted EPS up 17.3% to $2.24, fueled by smoke-free products hitting 41% of net revenues—up 2.9 points—via 16.6% volume growth. While combustibles dipped 3.2% in volume, pricing lifted revenues 4.3%. The company raised full-year adjusted EPS guidance to $7.46-$7.56, signaling robust momentum. Smoke-free margins expanded sharply.
8-K
PMI hikes dividend 8.9%
Philip Morris International boosted its quarterly dividend by 8.9% to $1.47 per share, lifting the annualized rate to $5.88, payable October 20, 2025, to shareholders of record October 3. This marks the 18th straight annual increase since 2008, totaling 219.6% growth at a 7.1% compound rate, signaling robust cash flow confidence amid its smoke-free pivot. Yet dividends remain a core return mechanism.
8-K
PMI reaffirms strong EPS growth
Philip Morris International's CEO Jacek Olczak presented at the 2025 Barclays Global Consumer Staples Conference on September 2, reaffirming the full-year forecast for adjusted diluted EPS of $7.43 to $7.56, signaling 13% to 15% growth from 2024's $6.57. Strong summer momentum in IQOS, ZYN, and VEEV persists, with U.S. ZYN offtake accelerating to 32% in early Q3. Yet competition intensifies. Forecasts hinge on volatile distributor inventories.
10-Q
Q2 FY2025 results
Philip Morris International's Q2 FY2025 results showed net revenues up 7.1% y/y to $10.1B, with smoke-free products driving 15.2% growth to $4.2B despite a 1.5% cigarette volume dip; operating income rose 7.8% y/y to $3.7B, boosted by pricing gains and volume/mix but tempered by $243M restructuring charges for German factory closures and a $41M goodwill impairment. Year-to-date, revenues climbed 6.5% y/y to $19.4B, with smoke-free up 15.1% y/y to $8.1B offsetting flat cigarette volumes; operating income increased 11.8% y/y to $7.3B, supported by favorable pricing and higher HTU shipments (up 10.5% y/y to 75.9B units). Cash stood at $4.1B with total debt at $51.5B, including $2.5B short-term borrowings; free cash flow was $2.3B (derived). Diluted EPS hit $1.95, up 26.6% y/y, reconciling to 1,558M shares. Yet regulatory hurdles persist in key markets.
BTI
British American Tobacco Indus
51.72-0.74
GRAM
GOLD FLORA CORP.
0.00+0.00
HCMC
Healthier Choices Management Co
0.00+0.00
ISPR
Ispire Technology Inc.
2.26+0.15
MO
Altria Group, Inc.
61.97-1.31
PYYX
Pyxus International, Inc.
2.25+0.00
RLX
RLX Technology Inc.
2.39-0.03
TOBAF
TAAT Global Alternatives Inc.
0.09+0.02
TPB
Turning Point Brands, Inc.
88.16-0.69
XXII
22nd Century Group, Inc
1.61+0.10